Homocysteine modulation as a reason for continuous folic acid supplementation in methotrexate-treated rheumatoid arthritis patients.
Erb
N
N
Kitas
G D
GD
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism*; D019587:Dietary Supplements; D005492:Folic Acid / Q000378:metabolism*; D006710:Homocysteine / Q000378:metabolism*; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000139:chemically induced / Q000378:metabolism
D018501:Antirheumatic Agents; D006710:Homocysteine; D005492:Folic Acid; D008727:Methotrexate